% Expired Patents = 14.3

EPO Patents = 5

Trademarks = 3

Forward Citations = 15

Loading Chart...

6 inventors (with patents filed for the assignee):

John Climax (7 out of 22 patents)

David Coughlan (5 out of 22 patents)

Jonathan Rowe (2 out of 8 patents)

4. Kevin Duffy (2 out of 2 patents)

5. Moayed Hamza (1 out of 1 patent)

6. Markus Weissbach (1 out of 1 patent)

7. Mehar Manku (107 patents)

7 patents: Sort by Forward Citations

1. 12274685 - Compositions comprising 15-HEPE and methods of using the same (2025-04-14),

2. 12076304 - Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases (2024-09-03),

3. 10813903 - Compositions comprising 15-HEPE and methods of using the same (2020-10-27),

4. 10716773 - Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease (2020-07-21),

5. 10363235 - Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same (2019-07-30),

6. 10231945 - Compositions comprising 15-HEPE and methods of using the same (2019-03-19),

7. 9855238 - Compositions comprising 15-HEPE and methods of using the same (2018-01-02),

Company Overview

Afimmune Limited is a biopharmaceutical company focused on the development of therapies for chronic inflammatory and metabolic diseases. Their lead compound, AF011, is designed to target multiple pathways involved in chronic inflammation and metabolic dysregulation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#9 in

#250 in Ireland

IE

Afimmune Limited

Forward Citations = 15

6 inventors:

John Climax (7 out of 22 patents)

David Coughlan (5 out of 22 patents)

Jonathan Rowe (2 out of 8 patents)

4. Kevin Duffy (2 out of 2 patents)

5. Moayed Hamza (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Afimmune Limited. Retrieved from https://idiyas.com/company/afimmune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]